ATE308988T1 - Verbesserte topische zusammensetzungen mit extrazellulären produkten von probiotischen bakterien und verwendungen davon - Google Patents

Verbesserte topische zusammensetzungen mit extrazellulären produkten von probiotischen bakterien und verwendungen davon

Info

Publication number
ATE308988T1
ATE308988T1 AT00961363T AT00961363T ATE308988T1 AT E308988 T1 ATE308988 T1 AT E308988T1 AT 00961363 T AT00961363 T AT 00961363T AT 00961363 T AT00961363 T AT 00961363T AT E308988 T1 ATE308988 T1 AT E308988T1
Authority
AT
Austria
Prior art keywords
compositions containing
probiotic bacteria
topical compositions
containing extracellular
improved topical
Prior art date
Application number
AT00961363T
Other languages
English (en)
Inventor
Sean Farmer
Original Assignee
Ganeden Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech Inc filed Critical Ganeden Biotech Inc
Application granted granted Critical
Publication of ATE308988T1 publication Critical patent/ATE308988T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/36—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
AT00961363T 1999-08-26 2000-08-25 Verbesserte topische zusammensetzungen mit extrazellulären produkten von probiotischen bakterien und verwendungen davon ATE308988T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/383,975 US6645506B1 (en) 1997-04-18 1999-08-26 Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
PCT/US2000/023300 WO2001013927A2 (en) 1999-08-26 2000-08-25 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof

Publications (1)

Publication Number Publication Date
ATE308988T1 true ATE308988T1 (de) 2005-11-15

Family

ID=23515538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00961363T ATE308988T1 (de) 1999-08-26 2000-08-25 Verbesserte topische zusammensetzungen mit extrazellulären produkten von probiotischen bakterien und verwendungen davon

Country Status (9)

Country Link
US (6) US6645506B1 (de)
EP (2) EP1632239A1 (de)
JP (1) JP2003507428A (de)
AT (1) ATE308988T1 (de)
AU (1) AU783418B2 (de)
CA (1) CA2382840C (de)
DE (1) DE60023919T2 (de)
ES (1) ES2256036T3 (de)
WO (1) WO2001013927A2 (de)

Families Citing this family (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
ATE493139T1 (de) * 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
EP1212093B1 (de) * 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AU783905B2 (en) * 1999-08-26 2005-12-22 Ganeden Biotech, Inc. Use of emu oil carrier for antifungal, antibacterial, and antiviral medications
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1110555A1 (de) 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora
JP4510376B2 (ja) * 2000-10-06 2010-07-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 皮膚の免疫系のバランスを保つためのプロバイオティック乳酸菌の使用
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
US20070190591A1 (en) * 2001-05-02 2007-08-16 Grech Nigel M Microbial compositions and methods of use in water
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2003039260A2 (en) * 2001-11-05 2003-05-15 Ganeden Biotech Inc Probiotic compositions
US6878373B2 (en) * 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
US7182943B2 (en) * 2002-05-15 2007-02-27 UNIVERSITé LAVAL Method and system for modulation of microbial cell characteristics
US7595065B2 (en) * 2002-06-25 2009-09-29 Wm. Wrigley Jr. Company Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils
US7632525B2 (en) * 2002-06-25 2009-12-15 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
US7347985B2 (en) * 2002-06-25 2008-03-25 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract
US7727549B2 (en) * 2002-07-15 2010-06-01 Alcon, Inc. Pharmaceutical compositions for otic use
WO2004067013A1 (en) * 2003-01-24 2004-08-12 Flora Technology Inc. Compositions and methods for restoring bacterial flora
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
US20050019379A1 (en) * 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
DK1506781T3 (da) * 2003-11-03 2005-06-13 Peter-Hansen Volkmann Vaginalplejesammensætning
EA010885B1 (ru) 2003-12-08 2008-12-30 Бентли Фармасьютикалз, Инк. Фармацевтические композиции и способы лечения инсулином
US20050226947A1 (en) * 2004-02-04 2005-10-13 Dale Kern Agents for sequestering serum aging factors and uses therefore
US7510734B2 (en) * 2004-03-04 2009-03-31 E-L Management Corporation Skin treatment method with Lactobacillus extract
WO2005086821A2 (en) * 2004-03-10 2005-09-22 Avia Candle Company Inc Antimicrobial wax composition for wax therapy
WO2006113925A2 (en) * 2005-04-20 2006-10-26 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
US7446904B2 (en) * 2004-05-28 2008-11-04 Infoprint Solutions Company, Llc Methods and apparatus for generating dither mask through interpolation between preferred patterns
US7252846B2 (en) * 2004-05-28 2007-08-07 Raied Dinno Topical composition and method for the treatment and prophylaxis of dermal irritations
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
US8092793B2 (en) * 2004-12-15 2012-01-10 Qingdao East Sea Pharmaceuticals, Ltd. Treating inflammatory bowel disease with live bacteria
WO2006076780A1 (en) * 2004-12-17 2006-07-27 Gielen Cornelis Use of non-pathogenic bacterial strains in cleaning and milking an animal
US20060147507A1 (en) * 2005-01-04 2006-07-06 Marie Cammarata Hot flash treatment system
WO2006115430A1 (en) * 2005-04-28 2006-11-02 Irina Grigorievna Osipova Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein
DE102005020457A1 (de) * 2005-04-29 2006-11-02 Westfaliasurge Gmbh Verwendung nicht-pathogener, sporenbildender Bakterien
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
CA2647374A1 (en) * 2005-10-24 2007-05-03 Staval Pharma, Ltd. Method for treating/controlling/killing fungi and bacteria
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
RU2287335C1 (ru) * 2005-12-15 2006-11-20 ООО Лаборатории технологии оздоровительных препаратов "Л-ТОП" Препарат для лечения заболеваний желудочно-кишечного тракта "бактистатин"
JP2009522330A (ja) * 2006-01-04 2009-06-11 マウデ ウィクストレム， 微生物の成長を刺激する口内用健康促進生成物
WO2007139601A2 (en) * 2006-02-21 2007-12-06 Bcr Diagnostics, Inc. Phenotypic engineering of spore
RU2314819C1 (ru) * 2006-06-23 2008-01-20 Александр Иванович Леляк Лечебно-профилактическое пробиотическое средство
CN101095698B (zh) * 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
CN109022302A (zh) 2006-08-11 2018-12-18 诺维信生物股份有限公司 细菌培养物和包含细菌培养物的组合物
US7858126B2 (en) 2006-08-31 2010-12-28 Trinity Laboratories Inc. Derivatives of sandalwood oil and santalols for treating cold sores and herpes
US20080075680A1 (en) * 2006-09-27 2008-03-27 Chen Jonathan Y Culture of microorganisms endogenous to plants and products thereof
US20080107699A1 (en) * 2006-10-25 2008-05-08 Mark Spigelman Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor
CN101134052A (zh) * 2006-11-17 2008-03-05 青岛东海药业有限公司 酪酸梭菌、凝结芽孢杆菌、双歧杆菌在制备防治口腔溃疡药物中的应用
JP2010511723A (ja) * 2006-12-04 2010-04-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 局所医薬組成物
FR2914189A1 (fr) * 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.
ES2597104T3 (es) 2007-04-19 2017-01-13 Mary Kay, Inc. Composiciones que contienen extracto de magnolia
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
TW200904340A (en) * 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
LT2211626T (lt) 2007-08-29 2019-11-11 Ganeden Biotech Inc Kepiniai
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
ES2461791T3 (es) * 2007-09-04 2014-05-21 L'oréal Utilización de una combinación de hesperidina y de un microorganismo para actuar sobre la función de barrera de la piel
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
LT2638807T (lt) * 2007-10-16 2021-08-25 Ganeden Biotech, Inc. Gėrimų kompozicija
US20090107007A1 (en) * 2007-10-31 2009-04-30 Mitchellace, Inc. Insole with included aloe extract
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
WO2009099562A2 (en) * 2008-01-30 2009-08-13 Ganeden Biotech, Inc. Compositions and methods for cleaning surfaces
US20090246152A1 (en) * 2008-03-28 2009-10-01 Nu Skin International, Inc. Naractin compositions for the inhibition of reactive oxygen species
US20090246153A1 (en) * 2008-03-28 2009-10-01 Nu Skin International, Inc. Cosmetic compositions for the inhibition of reactive oxygen species
US7788209B2 (en) * 2008-05-05 2010-08-31 United Technologies Corporation Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EP3508342A1 (de) * 2008-09-24 2019-07-10 Resilux Verfahren zur einbau von thermo-beständigen und / oder druckbeständigen organismen in materialien
WO2010045367A1 (en) * 2008-10-14 2010-04-22 Dr Pepper/Seven Up, Inc. Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
DK2348888T3 (en) 2008-10-16 2016-09-12 Ganeden Biotech Inc PROBIOTIC CORN-BASED COMPOSITIONS
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
DK2424550T3 (en) * 2009-04-29 2017-08-28 Ganeden Biotech Inc BACTERIAL CELL MEMBRANE formulation
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
FR2954140A1 (fr) * 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
EP2338331A1 (de) * 2009-12-22 2011-06-29 Research Center Pharmaceutical Engineering GmbH Verfahren und Zusammensetzungen zur biologischen Kontrolle des mikrobiellen Wachstums auf Reinraumausrüstungen
US20110229446A1 (en) * 2010-03-02 2011-09-22 Roman Stephen B Method and composition to relieve sexual discomfort and improve vaginal health
CN103037877A (zh) * 2010-03-12 2013-04-10 可尔必思株式会社 用于在大肠中增加双歧杆菌和抑制双歧杆菌减少的试剂
WO2011130487A1 (en) 2010-04-14 2011-10-20 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
KR20130045892A (ko) * 2010-06-24 2013-05-06 노보자임스 바이오로지컬스 인코포레이티드 체취를 감소시키는 방법 및 조성물
MX348937B (es) * 2010-08-25 2017-07-03 Tate & Lyle Ingredients Americas Llc Producto simbiotico.
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
FR2968991B1 (fr) * 2010-12-17 2013-01-11 Oreal " utilisation de population microbienne stable pour prevenir et/ou traiter les desordres des levres fragilisees ou endommagees"
WO2012085255A2 (en) * 2010-12-22 2012-06-28 Research Center Pharmaceutical Engineering Gmbh Volatile organic compounds from bacterial antagonists for controlling microbial growth
CN107815817A (zh) 2011-02-15 2018-03-20 诺维信生物股份有限公司 清洁机器及清洁方法中的气味的减轻
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US20120255334A1 (en) * 2011-04-08 2012-10-11 Stephen Gans Soluble organic fertilizer
US20120308490A1 (en) * 2011-06-06 2012-12-06 Abr Consulting S.R.L. Method of obtaining a preparation of biological origin for oral hygiene to prevent the onset of tooth decay
US9004374B1 (en) * 2011-07-20 2015-04-14 Stephen Gans Irrigation method using thixotropic materials
CN103468685B (zh) * 2012-01-05 2016-04-27 集美大学 嗜水气单胞菌适体及其筛选方法与应用
HK1205696A1 (en) 2012-04-20 2015-12-24 亨内平生命科学公司 Compositions for topical treatment of microbial infections
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
US9596861B2 (en) * 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
CN106456531B (zh) * 2014-03-31 2019-09-10 路博润先进材料公司 用于增加脂连蛋白水平的细菌菌株发酵提取物
CN104946550A (zh) * 2014-05-12 2015-09-30 山东黎昊源生物工程有限公司 一种保叶生物菌株修复剂
BR112016026359B1 (pt) 2014-05-13 2022-03-22 Microbial Discovery Group, Llc Métodos para controlar os efeitos ambientais prejudiciais do esterco e para alimentar um animal, embalagem, aditivos de ração e para água potável, e composição de ração
US10004768B2 (en) * 2014-09-25 2018-06-26 Iryohojin Kiyokai Treatment of atopic dermatitis and infectious dermatitis with biological spa therapy
EA027597B1 (ru) * 2014-10-09 2017-08-31 Александр Владимирович Синица Композиция с пробиотической, гепатопротекторной, антиоксидантной и иммуномодулирующей активностью
EP3294308A4 (de) 2015-05-14 2019-03-06 University of Puerto Rico Verfahren zur wiederherstellung der biozönose von neugeborenen
CN105132307B (zh) * 2015-07-22 2017-12-12 江南大学 一种应用于观赏鱼的复合芽孢杆菌微生物净水剂及其应用
DE102015010874B4 (de) * 2015-08-25 2017-06-14 Fritz Stephan Gmbh Medizintechnik Anzug für ein Neugeborenes, insbesondere ein Frühgeborenes
JP6790104B2 (ja) * 2015-10-30 2020-11-25 ゼット プロバイオティクス インコーポレイテッド ディービーエイ ゼット バイオサイエンス インコーポレイテッド プロバイオティック組成物及びその使用
US12157690B2 (en) * 2015-12-09 2024-12-03 Microbial Discovery Group Llc Cold temperature-resistant microbials and methods of their use
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
US10335440B2 (en) 2016-02-29 2019-07-02 Microbial Discovery Group, Llc Direct-fed microbials
CA3018768C (en) 2016-03-31 2024-03-26 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
EP3436028A1 (de) * 2016-03-31 2019-02-06 Gojo Industries, Inc. Topische zusammensetzung zur reduzierung von pathogenbindung
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
SG11201809100QA (en) * 2016-04-19 2018-11-29 Us Health Use of gram negative species to treat atopic dermatitis
AR108659A1 (es) * 2016-06-03 2018-09-12 Valent Biosciences Llc Composiciones no acuosas, no oleosas con bacillus amyloliquefaciens
MX2019002978A (es) * 2016-09-14 2019-09-18 Grace Breeding Ltd Composiciones que comprenden una bacteria no patogena y metodos para proteger plantas y animales anfitriones contra enfermedades micoticas, bacterianas y virales.
BE1024189B1 (nl) * 2016-10-28 2017-12-05 Yun NV Spuitbus met bacteriële species
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
IT201700005552A1 (it) * 2017-01-19 2018-07-19 Copma S C A R L Prodotto eutrofizzante per uso cosmetico
CN111093622A (zh) * 2017-06-06 2020-05-01 萨米莱布斯有限公司 来自凝结芽孢杆菌的胞外代谢物的皮肤护理应用
CN110996902A (zh) * 2017-06-06 2020-04-10 萨米莱布斯有限公司 从凝结芽孢杆菌mtcc 5856分离的胞外代谢物的抗衰老潜力
CA3064914A1 (en) * 2017-06-06 2018-12-13 Sami Labs Limited Hair care compositions containing extracellular metabolite preparation from bacillus coagulans
WO2019018944A1 (en) * 2017-07-28 2019-01-31 Davincia Inc. TOPICAL COMPOSITION FOR REJUVENATING AND / OR REPAIRING THE SKIN, METHODS, USES AND KITS THEREOF
EP3678636A4 (de) * 2017-09-07 2021-06-09 Technion Research & Development Foundation Limited Topische kits und zusammensetzungen und verwendung davon
CA3083777C (en) * 2017-12-04 2024-03-26 Sami Labs Limited Compositions for microbial anti-adhesion
US12163135B2 (en) 2017-12-05 2024-12-10 BioPlx, Inc. Methods and compositions to prevent microbial infection
WO2019212379A1 (ru) * 2018-05-04 2019-11-07 Farber Boris Slavinovich Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом
FR3085687B1 (fr) * 2018-09-07 2021-05-14 Nolivade Composition et procede de conservation
CN113164529B (zh) 2018-10-02 2024-12-24 微生物发现集团有限责任公司 用于动物的微生物
WO2020072642A1 (en) * 2018-10-02 2020-04-09 Nutech Ventures Novel gras probiotic bacterial strain to inhibit acidosis and liver abscesses in cattle
MX2021006674A (es) * 2018-12-05 2021-07-07 Seres Therapeutics Inc Composiciones para estabilizar bacterias y usos de las mismas.
CA3123051A1 (en) * 2018-12-19 2020-06-25 Healthy Cow Corporation Ready-to-use probiotic compositions and uses thereof
CA3126395A1 (en) * 2019-01-15 2020-07-23 Novozymes A/S Spore-based probiotic composition for modulation of dermal and sub-dermal properties
CN109464313A (zh) * 2019-01-22 2019-03-15 杭州百芮生物科技有限公司 一种皮肤外用精华液的制备方法及生物纤维素膜片
MX2021011288A (es) * 2019-03-19 2021-10-13 Microbial Discovery Group Llc Cepas microbianas para la inhibicion de virus.
KR20220003539A (ko) 2019-04-09 2022-01-10 덤바이온트, 인코포레이티드 피부 건강을 개선하기 위한 그리고 병원성 미소생물과 연관된 질환, 장애 및 병태의 치료 및 예방을 위한 조성물 및 방법
CN114929027A (zh) 2019-08-22 2022-08-19 微生物发现集团有限责任公司 用微生物菌株和抗生素的抑制方法
CA3192065A1 (en) 2020-08-21 2022-02-24 Microbial Discovery Group, Llc Microbials and antibiotics
BR112023002974A2 (pt) 2020-08-21 2023-04-04 Microbial Discovery Group Llc Cepas microbianas e antibióticos
CN113699085B (zh) * 2021-11-01 2022-02-08 渤海水产科技(滨州)有限公司 拮抗菌ed5及其应用
CN114767936B (zh) * 2022-05-10 2023-04-18 武汉理工大学 复合干酪乳杆菌的皮肤损伤修复支架材料制备方法
CN115074286B (zh) * 2022-07-01 2023-06-06 安徽农业大学 一株拮抗足癣病原真菌的短小芽孢杆菌及其应用
CN116064330B (zh) * 2023-01-10 2024-05-03 北京工商大学 凝结芽孢杆菌及其应用
KR20250158049A (ko) * 2023-03-16 2025-11-05 뉴트리션 앤드 바이오사이언시스 유에스에이 4, 인크. 악취 제어를 위한 퍼스널 케어 조성물 및 이의 방법
CN120757613B (zh) * 2025-09-11 2025-11-14 齐鲁工业大学(山东省科学院) 具有抗氧化、抗衰老活性的大豆活性肽及其制备方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7401939A (nl) * 1974-02-13 1975-08-15 Philips Nv Ladingsgekoppelde inrichting.
US4062943A (en) * 1974-11-20 1977-12-13 Board Of Supervisors Louisiana State University A & M Antibiotic produced from the microorganism (Pseudomonas lindbergii), its preparation and method of use
US4323651A (en) * 1974-12-04 1982-04-06 R. J. Reynolds Tobacco Company Thermostable lactase derived from bacillus
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
JPH01199575A (ja) * 1988-02-04 1989-08-10 Rikagaku Kenkyusho 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
AT391323B (de) 1989-03-10 1990-09-25 Jungbunzlauer Ag Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
US5371011A (en) * 1989-07-10 1994-12-06 Zeneca Corp. Mold control in forage
FR2656314B1 (fr) * 1989-12-22 1992-04-17 Bp Chemicals Snc Catalyseur a base de zirconium supporte sur du chlorure de magnesium, procede de preparation et utilisation du catalyseur dans la polymerisation des olefines.
DE4001611C1 (de) * 1990-01-20 1991-02-28 Skw Trostberg Ag, 8223 Trostberg, De
US5200336A (en) * 1990-07-02 1993-04-06 New England Biolabs, Inc. Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same
JP3172177B2 (ja) 1990-11-14 2001-06-04 イミュー プロダクツ ウェスターン オーストレイリア ピーティーワイ． リミテッド エミュー油から誘導した抗炎性混合物
IT1262927B (it) 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
FI92498C (fi) * 1992-06-10 1994-11-25 Valio Meijerien Uusi mikro-organismikanta, sitä sisältävät bakteerivalmisteet ja näiden käyttö hiivojen ja homeiden torjuntaan
JPH06166623A (ja) * 1992-09-25 1994-06-14 Toyama Chem Co Ltd 抗菌性組成物
WO1994011492A1 (en) 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
US6103246A (en) * 1993-06-03 2000-08-15 Tisdale; Carrie J. Creams and lotions containing emu oil
US5540920A (en) * 1994-11-22 1996-07-30 Olin Corporation Synergistic biocide composition containing pyrithione plus an additive
US5472713A (en) * 1994-11-23 1995-12-05 Elf Resources, Inc. Therapeutic uses of emu oil
SE9502588L (sv) 1995-07-13 1997-01-14 Moelnlycke Ab Hämning av tillväxten av bakterier i samband med absorberande alster med hjälp av tillsats av andra bakterier
US5698227A (en) * 1996-07-23 1997-12-16 Rivlin; Daniel Compositions comprising lidocaine and emu oil and methods of use thereof
ATE493139T1 (de) 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO1998054982A1 (en) * 1997-06-03 1998-12-10 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with sids
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6261577B1 (en) * 1997-07-16 2001-07-17 Symbollon Corporation Non-staining topical iodine composition and method
US6312703B1 (en) * 1998-02-06 2001-11-06 Lecigel, Llc Compressed lecithin preparations
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
CA2339643A1 (en) 1998-08-07 2000-02-17 Ganeden Biotech, Inc. Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
WO2000061201A1 (en) 1999-04-14 2000-10-19 Ganeden Biotech, Inc. Methods for inhibiting microbial infections associated with sanitary products
EP1212093B1 (de) * 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
US6416772B1 (en) * 2001-01-12 2002-07-09 H. Wayne Van Engelen Topical dermal anaesthetic
WO2003039260A2 (en) * 2001-11-05 2003-05-15 Ganeden Biotech Inc Probiotic compositions
US20030143262A1 (en) * 2001-12-13 2003-07-31 Brusk Ulla Forsgren Hygiene tissue
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin

Also Published As

Publication number Publication date
ES2256036T3 (es) 2006-07-16
US6645506B1 (en) 2003-11-11
AU7332400A (en) 2001-03-19
EP1632239A1 (de) 2006-03-08
EP1212069B1 (de) 2005-11-09
US20050271758A1 (en) 2005-12-08
WO2001013927A2 (en) 2001-03-01
US7544363B2 (en) 2009-06-09
WO2001013927A3 (en) 2001-08-30
US6723326B1 (en) 2004-04-20
US20030003107A1 (en) 2003-01-02
US20090238907A1 (en) 2009-09-24
WO2001013927A9 (en) 2002-07-11
US20080089963A1 (en) 2008-04-17
US7807185B2 (en) 2010-10-05
JP2003507428A (ja) 2003-02-25
EP1212069A2 (de) 2002-06-12
CA2382840C (en) 2011-05-24
US7541042B2 (en) 2009-06-02
US6905692B2 (en) 2005-06-14
DE60023919D1 (de) 2005-12-15
DE60023919T2 (de) 2006-08-10
CA2382840A1 (en) 2001-03-01
AU783418B2 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
ATE308988T1 (de) Verbesserte topische zusammensetzungen mit extrazellulären produkten von probiotischen bakterien und verwendungen davon
ATE331532T1 (de) Pulverförmige pernasale mittel
DE69735776D1 (de) Bacillus thuringiensis cryet33 und cryet34 enthaltende zusammensetzungen und derren verwendungen
ATE163042T1 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
BG64475B1 (bg) Ципразидонови соли
HUP0104795A3 (en) Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use
AU4879396A (en) Use of inorganic aerogels in pharmacy
EG22469A (en) Web materials with two or more skin care compositions disposed thereon and articles made therefrom
DE69801976D1 (de) Zusammensetzung und Gegenstand mit verbessertem Druckverformungsrest
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
ATE151278T1 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
EE03680B1 (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
AU8978198A (en) Pharmaceutical compositions containing vitamin d and calcium, their prep aration and therapeutic use
AU5234199A (en) Composition useful for softening, cleaning, and personal care applications
BR0012992A (pt) Bifidobactérias que previnem a diarréia causada por bactérias patogênicas
BG105256A (en) Muscarinic agonists and antagonists
IL134001A0 (en) Active oxygen scavenger compositions and their use in packaging articles
EP0672052A1 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen.
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
AR021159A1 (es) Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
NO943374D0 (no) Psylliumholdig materialsammensetning
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
TR199900141T2 (xx) Bunama tedavisi ve/veya profilaksisi i�in form�lasyon.
ATE251619T1 (de) 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1212069

Country of ref document: EP